Mucos Pharma GmbH & Co. KG
3 clinical trials · Sponsor
◉ Watch Mucos Pharma GmbH & Co. KG
| Record | Firm | Date |
|---|---|---|
| Study to Investigate the Mechanism of Action of an Oral Enzyme Treatment With Bromelain, Trypsin and Rutoside Versus Placebo in Subjects With OsTeoarthritis (NCT05038410) | Mucos Pharma GmbH & Co. KG | 2021-04-30 |
Track Mucos Pharma GmbH & Co. KG automatically
Every clearance here is in the API, with alerts when new ones post.